{
    "nctId": "NCT02671318",
    "officialTitle": "Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence in Kidney Transplant Recipients (StopCMV: S=Sirolimus CMV= Cytomegalovirus)",
    "inclusionCriteria": "* Adult kidney transplant recipients \\> 18 y.o.\n* Kidney Transplant recipients, after the first episode of cytomegalovirus infection, using the current immunosuppressive regimen: azathioprine or mycophenolate, tacrolimus and prednisone.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Re-transplant;\n* Patients with any panel reactive antibody (PRA) equal to or above 50%, class I or class II;\n* Acute rejection episode in the last 30 days, or episode \\> 2A in the Banff criteria;\n* GFR (MDRD) \\< 40 ml/min;\n* Proteinuria \\> 0,5 g/l;\n* Hemoglobin \\< 10 g/l and/or leucocytes \\< 4000 cels/mm3 and/or platelets \\< 150.000 cels/mm3;\n* Triglycerides \\> 500 mg/dl with or without use of fibrate;\n* Cholesterol total \\> 300 mg/dl with or without use of statin;\n* Hepatic abnormalities;\n* Significant periphery edema;\n* Pulmonary abnormalities or breast x-ray abnormalities;\n* Hyper sensibility to sirolimus formula;"
}